Item 7.01. Regulation FD Disclosure.
BeiGene, Ltd. (the "Company") will be meeting with investors at the J.P. Morgan
39th Annual Healthcare Conference during the week of January 10, 2021 in San
Francisco (the "J.P. Morgan Conference"). A copy of the Company's presentation
to be shared with investors at the J.P. Morgan Conference is attached as Exhibit
99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The presentation shall not be deemed to be "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing or this Current Report.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Company Presentation dated January 10, 2021.
104 The cover page from this Current Report on Form 8-K, formatted in
Inline XBRL.
--------------------------------------------------------------------------------
Exhibit Index
Exhibit No. Description
99.1 Company Presentation dated January 10 , 2021.
104 The cover page from this Current Report on Form 8-K, formatted in
Inline XBRL.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses